NCT01989156View on ClinicalTrials.gov

Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting Followed by 86 Days in an Ambulatory Setting

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

May 31, 2015

Conditions
Smoking
Interventions
OTHER

THS 2.2 Menthol (mTHS 2.2)

THS 2.2 Menthol ad libitum for 5 days in confinement prolonged by 86 days in an ambulatory setting

OTHER

Menthol Conventional Cigarette (mCC)

Subject's own preferred brand of mCC ad libitum for 5 days in confinement prolonged by 86 days in an ambulatory setting

OTHER

Smoking Abstinence (SA)

SA for 5 days in confinement prolonged by 86 days in an ambulatory setting

Trial Locations (2)

32117

Covance Daytona Beach, 1900 Mason Ave., Suite 140, Daytona Beach

75247

Covance Dallas, 1341 W. Mockingbird Ln., Ste 400E, Dallas

All Listed Sponsors
lead

Philip Morris Products S.A.

INDUSTRY

NCT01989156 - Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting Followed by 86 Days in an Ambulatory Setting | Biotech Hunter | Biotech Hunter